Open AccessStudy of the use possibility of the chemical-biological adduct of the 1,1-bis-[5-bromopyrimidine-2’,4’-diono-1’-il]-2-bromo-2’-chloroethylene and bacterial lectin for the treatment of the Pliss’ lymphosarcoma
Zaporozhye Medical JournalPeer ReviewedOlena WELCHINSKA2015Journals
The content you want is available to Zendy users.
Already have an account? Sign inHaving issues? Contact support